Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generate Biomedicines
Biotech
Generate gains another $1B-plus Big Pharma partner in Novartis
Novartis has inked a deal potentially worth more than $1 billion with Flagship's Generate to develop protein therapeutics across multiple indications.
Gabrielle Masson
Sep 24, 2024 6:00am
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
AI can make plenty of molecules, Generate can't do it alone
Jan 4, 2024 6:00am
Generate raises huge $273M series C, a little short of 2021 haul
Sep 14, 2023 6:00am
Fierce Biotech's 2022 Fierce 15
Sep 12, 2022 3:00am
Amgen vet to be CMO at Affini-T—Chutes & Ladders
Jul 29, 2022 9:30am